Is clinical remission the optimum therapeutic goal in the treatment of Crohn's disease?
- 27 April 2002
- journal article
- review article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 16 (5), 857-867
- https://doi.org/10.1046/j.1365-2036.2002.01242.x
Abstract
Currently, the therapeutic end-point in the treatment of Crohn's disease is the remission of symptoms, but recent data confirm that mucosal inflammation may continue in the absence of symptoms. Furthermore, emerging evidence indicates that such subtle, sub-clinical mucosal inflammation leads to clinical relapse. The assessment of mucosal inflammation has become easier with the availability of faecal calprotectin assay. Current anti-inflammatory therapy often leaves low-grade mucosal inflammation untreated, and therefore recurrent relapses occur. We need to investigate whether the therapeutic end-point of anti-inflammatory medications needs to be more rigorous and to aim at complete mucosal healing, confirmed by the normalization of mucosal inflammatory markers such as faecal calprotectin concentrations. Immunosuppressive therapy with azathioprine/ 6-mercaptopurine currently offers the best mucosal healing treatment with reduction of relapses, but newer biological agents might offer less toxic therapy. Clinical trials to test the feasibility and efficacy of such a paradigm shift in the medical management of Crohn's disease are now warranted.This publication has 70 references indexed in Scilit:
- General and cancer specific mortality of a population based cohort of patients with inflammatory bowel disease: the Florence studyGut, 1998
- Anal lesions: any significant prognosis in Crohnʼs disease?European Journal of Gastroenterology & Hepatology, 1997
- Factors Influencing First Relapse in Patients with Crohnʼs DiseaseJournal of Clinical Gastroenterology, 1992
- Analysis of clinical course of postoperative recurrence in Crohn's Disease of distal ileumDigestive Diseases and Sciences, 1992
- Prognostic Significance of Epithelioid Granulomas Found in Rectosigmoid Biopsies at the Initial Presentation of Pediatric Crohnʼs DiseaseJournal of Pediatric Gastroenterology and Nutrition, 1989
- Discriminant Function Analysis to Calculate a Crohn??s Activity Group Scale to Predict Future Inactive or Active DiseaseJournal of Clinical Gastroenterology, 1988
- Predicting relapses of Crohn's diseaseDigestive Diseases and Sciences, 1987
- Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease.Gut, 1986
- European Cooperative Crohn’s Disease Study (ECCDS): Clinical Features and Natural HistoryDigestion, 1985
- Recurrence and Reoperation for Crohn's DiseaseThe New England Journal of Medicine, 1981